These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 22949650)
1. Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer. Tucci P; Agostini M; Grespi F; Markert EK; Terrinoni A; Vousden KH; Muller PA; Dötsch V; Kehrloesser S; Sayan BS; Giaccone G; Lowe SW; Takahashi N; Vandenabeele P; Knight RA; Levine AJ; Melino G Proc Natl Acad Sci U S A; 2012 Sep; 109(38):15312-7. PubMed ID: 22949650 [TBL] [Abstract][Full Text] [Related]
2. Synergetic Effects of Intronic Mature miR-944 and ΔNp63 Isoforms on Tumorigenesis in a Cervical Cancer Cell Line. Kim J; Park S; Chang Y; Park KH; Lee H Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32764455 [No Abstract] [Full Text] [Related]
3. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Zhao Z; Zhao S; Luo L; Xiang Q; Zhu Z; Wang J; Liu Y; Luo J Br J Cancer; 2021 Mar; 124(5):982-994. PubMed ID: 33239676 [TBL] [Abstract][Full Text] [Related]
4. MiR-301a regulates E-cadherin expression and is predictive of prostate cancer recurrence. Nam RK; Benatar T; Wallis CJ; Amemiya Y; Yang W; Garbens A; Naeim M; Sherman C; Sugar L; Seth A Prostate; 2016 Jul; 76(10):869-84. PubMed ID: 26990571 [TBL] [Abstract][Full Text] [Related]
5. The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior. Bornachea O; López-Calderón FF; Dueñas M; Segrelles C; Lorz C; Suárez-Cabrera C; Marañón M; Paradela-Dobarro B; Santos M; Paramio JM Oncotarget; 2015 Sep; 6(27):24230-45. PubMed ID: 26203771 [TBL] [Abstract][Full Text] [Related]
6. Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors. Gunaratne PH; Pan Y; Rao AK; Lin C; Hernandez-Herrera A; Liang K; Rait AS; Venkatanarayan A; Benham AL; Rubab F; Kim SS; Rajapakshe K; Chan CK; Mangala LS; Lopez-Berestein G; Sood AK; Rowat AC; Coarfa C; Pirollo KF; Flores ER; Chang EH Cancer; 2019 Jul; 125(14):2409-2422. PubMed ID: 31012964 [TBL] [Abstract][Full Text] [Related]
7. The p63 protein isoform ΔNp63α inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. Tran MN; Choi W; Wszolek MF; Navai N; Lee IL; Nitti G; Wen S; Flores ER; Siefker-Radtke A; Czerniak B; Dinney C; Barton M; McConkey DJ J Biol Chem; 2013 Feb; 288(5):3275-88. PubMed ID: 23239884 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1. Sun B; Fan Y; Yang A; Liang L; Cao J J Cell Mol Med; 2019 Sep; 23(9):5934-5948. PubMed ID: 31298493 [TBL] [Abstract][Full Text] [Related]
9. The guardians of the genome (p53, TA-p73, and TA-p63) are regulators of tumor suppressor miRNAs network. Boominathan L Cancer Metastasis Rev; 2010 Dec; 29(4):613-39. PubMed ID: 20922462 [TBL] [Abstract][Full Text] [Related]
10. A double dealing tale of p63: an oncogene or a tumor suppressor. Chen Y; Peng Y; Fan S; Li Y; Xiao ZX; Li C Cell Mol Life Sci; 2018 Mar; 75(6):965-973. PubMed ID: 28975366 [TBL] [Abstract][Full Text] [Related]
11. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition. Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2. Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091 [TBL] [Abstract][Full Text] [Related]
14. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo. Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903 [TBL] [Abstract][Full Text] [Related]
16. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition. Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614 [TBL] [Abstract][Full Text] [Related]
17. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma. Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590 [TBL] [Abstract][Full Text] [Related]
18. Distinct TP63 Isoform-Driven Transcriptional Signatures Predict Tumor Progression and Clinical Outcomes. Abbas HA; Bui NHB; Rajapakshe K; Wong J; Gunaratne P; Tsai KY; Coarfa C; Flores ER Cancer Res; 2018 Jan; 78(2):451-462. PubMed ID: 29180475 [TBL] [Abstract][Full Text] [Related]
19. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
20. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]